Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02717065
Other study ID # 1512M81434
Secondary ID
Status Withdrawn
Phase N/A
First received March 17, 2016
Last updated September 13, 2017
Start date June 2017
Est. completion date January 2018

Study information

Verified date September 2017
Source University of Minnesota - Clinical and Translational Science Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Characterizing the nature and severity of tinnitus in individuals presents a particular challenge. The nature of the sound (loudness and pitch) is not necessarily indicative of the effect on quality of life. Different methods are used to measure each parameter. Loudness is measured using a technique called "minimum masking," in which the subject is presented with a broadband white noise and asked to adjust the loudness level until they can no longer hear their tinnitus. Severity of tinnitus is commonly characterized using two questionnaires: the Tinnitus Handicap Inventory (THI) and the Tinnitus Functional Index (TFI). These questionnaires assess the perceived severity of the tinnitus and the effect on everyday activities and quality of life. A visual analog scale (a scale from 0-10) is used as a general subjective measurement of tinnitus severity. In the first part of this study, we will measure each of these parameters over a series of sessions to establish a baseline variability for each individual.

The second part will look at the influence of context-specific visual information on auditory perception. This involves watching silent videos of a person speaking, with and without an additional tone designed to match the subject's tinnitus. The effect of this audiovisual feedback on the subject's perception of tinnitus will be assessed using a subjective rating scale and the minimum masking task.


Description:

This study is not specifically seeking to treat tinnitus, but is designed to investigate various parameters that can alter the tinnitus percept. Findings from this study will help identify parameters that can be more effective at decreasing or fully suppressing the tinnitus percept that will be systematically explored in a follow-up study.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Have subjective, non-pulsatile and bothersome tinnitus

- Ability to give informed consent and understand study objectives and procedures in English

- Willing and able to understand and comply with all study-related procedures

- Will not start any new tinnitus treatment during the study

Exclusion Criteria:

- Substantial hearing loss or hyperacusis that may interfere with the study

- Medical history of other ear or brain disorders

- Pregnant or currently breast-feeding (we need to give all female subjects a pregnancy test because pregnant females and unborn children require extra protection for their safety)

- Any handicap that prevents the subject from reliably performing the tests, such as blindness.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Tone
Band-limited white noise stimulus or frequency-matched tone presented at a comfortable loudness level via headphones or earphones.
Video
Silent video recording of a person speaking or a still face with an expanding circle over the mouth presented on a computer or tablet screen.

Locations

Country Name City State
United States University of Minnesota, Nils Hasselmo Hall, 6-105 Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota - Clinical and Translational Science Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Minimal Masking Level A narrowband noise (from 2-12 kHz) is presented to the tinnitus ear and the minimum sound level (in decibel sound pressure level, decibel SPL) is determined that completely masks the tinnitus percept. Change in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigm.
Primary Change in Tinnitus Rating (0-10, 10 being worst) the subject rates the disturbance or bothering nature of the tinnitus. Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigm
Secondary Change in Tinnitus Functional Index Questionnaire Score A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score. Change from baseline score at an expected average of 5 minutes and 1.5 hours after testing paradigm
Secondary Change in Tinnitus Handicap Inventory Questionnaire Score A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score. Change from baseline score at an expected average of 5 minutes and 1.5 hours after testing paradigm
Secondary Change in Tinnitus Subjective Description The subject describes the quality, characteristics, and bothering nature of the tinnitus. Change in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigm
See also
  Status Clinical Trial Phase
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed NCT03552302 - Effects of Yoga Exercise on Participates With Tinnitus
Enrolling by invitation NCT02617953 - Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus N/A
Withdrawn NCT01663467 - Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy N/A
Completed NCT02269839 - A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus N/A
Completed NCT02974543 - Somatosensory Stimulation to Alleviate Tinnitus N/A
Completed NCT01929837 - Tinnitus rTMS 2013 N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Completed NCT01927991 - Internet-based Self-help for Tinnitus: The Role of Support N/A
Terminated NCT01412918 - Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression N/A
Completed NCT01480193 - New Therapy for Patients With Severe Tinnitus N/A
Completed NCT00748475 - Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus N/A
Completed NCT00371436 - Progressive Intervention Program for Tinnitus Management N/A
Completed NCT00733044 - Cost-effectiveness of Multidisciplinary Management of Tinnitus N/A
Active, not recruiting NCT05518682 - Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus N/A
Recruiting NCT05212298 - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus N/A
Completed NCT06025097 - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus. Early Phase 1